|
US9028822B2
(en)
|
2002-06-28 |
2015-05-12 |
Domantis Limited |
Antagonists against TNFR1 and methods of use therefor
|
|
US9321832B2
(en)
*
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
WO2010081856A1
(en)
*
|
2009-01-14 |
2010-07-22 |
Ablynx Nv |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
EP1558647B1
(en)
*
|
2002-11-08 |
2015-06-10 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
WO2004041862A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
GB0521621D0
(en)
|
2005-10-24 |
2005-11-30 |
Domantis Ltd |
Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases
|
|
CN101454344A
(zh)
*
|
2005-12-01 |
2009-06-10 |
杜门蒂斯有限公司 |
与白细胞介素-1受体1型结合的非竞争性域抗体形式
|
|
CA2629850A1
(en)
*
|
2005-12-01 |
2007-06-07 |
Domantis Limited |
Competitive domain antibody formats that bind interleukin 1 receptor type 1
|
|
AU2013270447B2
(en)
*
|
2006-08-10 |
2016-10-13 |
Onspira Therapeutics, Inc. |
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
|
|
CA2660519A1
(en)
*
|
2006-08-10 |
2008-02-21 |
Roy C. Levitt |
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
|
|
GB0621513D0
(en)
*
|
2006-10-30 |
2006-12-06 |
Domantis Ltd |
Novel polypeptides and uses thereof
|
|
EA200901494A1
(ru)
*
|
2007-06-06 |
2010-06-30 |
Домантис Лимитед |
Способы селекции протеазоустойчивых полипептидов
|
|
GB0724331D0
(en)
|
2007-12-13 |
2008-01-23 |
Domantis Ltd |
Compositions for pulmonary delivery
|
|
AU2008297927A1
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of Trp6-Triptorelin and D-Leu6-Leuprolide as therapeutic agents
|
|
EP2197463A2
(en)
*
|
2007-09-11 |
2010-06-23 |
Mondobiotech Laboratories AG |
Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
|
|
US20100260853A1
(en)
*
|
2007-12-13 |
2010-10-14 |
Amrik Basran |
Compositions for pulmonary delivery
|
|
US8753690B2
(en)
|
2008-02-27 |
2014-06-17 |
Biomet Biologics, Llc |
Methods and compositions for delivering interleukin-1 receptor antagonist
|
|
PL2259774T3
(pl)
|
2008-02-27 |
2013-04-30 |
Biomet Biologics Llc |
Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1
|
|
JP2011516603A
(ja)
|
2008-04-17 |
2011-05-26 |
アブリンクス エン．ヴェー． |
血清タンパク質と結合することが可能なペプチド、並びにこれを含む化合物、構築物及びポリペプチド
|
|
MX2011004244A
(es)
*
|
2008-10-21 |
2011-05-25 |
Domantis Ltd |
Ligandos que tienen especificidad de enlace para dc-sign.
|
|
EP2362767B1
(en)
|
2008-10-29 |
2017-12-06 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
|
KR20110079693A
(ko)
|
2008-10-29 |
2011-07-07 |
와이어쓰 엘엘씨 |
단일 도메인 항원 결합 분자의 정제 방법
|
|
US8298533B2
(en)
*
|
2008-11-07 |
2012-10-30 |
Medimmune Limited |
Antibodies to IL-1R1
|
|
WO2010056732A1
(en)
|
2008-11-12 |
2010-05-20 |
Marv Enterprises Llc |
Utilization of stents for the treatment of blood borne carcinomas
|
|
WO2010107789A1
(en)
*
|
2009-03-17 |
2010-09-23 |
Marv Enterprises Llc |
Sequential extracorporeal treatment of bodily fluids
|
|
US20100291106A1
(en)
*
|
2009-05-06 |
2010-11-18 |
Novartis Ag |
Compositions and methods for antibodies targeting complement protein c3b
|
|
EP2438087B1
(en)
*
|
2009-06-05 |
2017-05-10 |
Ablynx N.V. |
Trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections
|
|
EP2470162B1
(en)
|
2009-08-27 |
2019-03-27 |
Biomet Biologics, LLC |
Implantable device for production of interleukin-1 receptor antagonist
|
|
CA2788993A1
(en)
|
2010-02-05 |
2011-08-11 |
Ablynx N.V. |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
|
|
KR20130086141A
(ko)
*
|
2010-04-16 |
2013-07-31 |
메디뮨 리미티드 |
Ｃｏｐｄ 악화를 치료하기 위한 조성물 및 방법
|
|
US8883134B2
(en)
|
2010-10-20 |
2014-11-11 |
Handok Pharmaceuticals, Inc. |
Human interleukin-1 receptor antagonist—hybrid Fc fusion protein
|
|
WO2012053828A2
(ko)
*
|
2010-10-20 |
2012-04-26 |
주식회사 한독약품 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
JP2014501515A
(ja)
*
|
2010-12-01 |
2014-01-23 |
グラクソ グループ リミテッド |
改良された抗血清アルブミン結合単一可変ドメイン
|
|
US20140011728A1
(en)
*
|
2011-02-15 |
2014-01-09 |
Novo Nordisk A/S |
Long-acting il-1 receptor antagonists
|
|
EP4350345A3
(en)
|
2011-06-23 |
2024-07-24 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
RS55775B2
(sr)
|
2011-06-23 |
2022-10-31 |
Ablynx Nv |
Tehnike za predviđanje, otkrivanje i smanjenje nespecifične proteinske interferencije u testovima koji uključuju pojedinačne varijabilne domene imunoglobulina
|
|
PH12022550313A1
(en)
|
2011-06-23 |
2023-01-23 |
Ablynx Nv |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
WO2013148405A2
(en)
*
|
2012-03-27 |
2013-10-03 |
Felder Mitchell S |
Treatment for atherosclerosis
|
|
US10208095B2
(en)
|
2013-03-15 |
2019-02-19 |
Biomet Manufacturing, Llc |
Methods for making cytokine compositions from tissues using non-centrifugal methods
|
|
US9895418B2
(en)
|
2013-03-15 |
2018-02-20 |
Biomet Biologics, Llc |
Treatment of peripheral vascular disease using protein solutions
|
|
US9950035B2
(en)
|
2013-03-15 |
2018-04-24 |
Biomet Biologics, Llc |
Methods and non-immunogenic compositions for treating inflammatory disorders
|
|
US9758806B2
(en)
|
2013-03-15 |
2017-09-12 |
Biomet Biologics, Llc |
Acellular compositions for treating inflammatory disorders
|
|
US20140271589A1
(en)
|
2013-03-15 |
2014-09-18 |
Biomet Biologics, Llc |
Treatment of collagen defects using protein solutions
|
|
US9878011B2
(en)
|
2013-03-15 |
2018-01-30 |
Biomet Biologics, Llc |
Treatment of inflammatory respiratory disease using biological solutions
|
|
US10143725B2
(en)
|
2013-03-15 |
2018-12-04 |
Biomet Biologics, Llc |
Treatment of pain using protein solutions
|
|
US9833474B2
(en)
|
2013-11-26 |
2017-12-05 |
Biomet Biologies, LLC |
Methods of mediating macrophage phenotypes
|
|
DK3143403T3
(da)
|
2014-05-16 |
2022-01-17 |
Ablynx Nv |
Fremgangsmåder til påvisning og/eller måling af anti-lægemiddelantistoffer, især behandlingsinducerede anti-lægemiddelantistoffer
|
|
HUE050007T2
(hu)
|
2014-05-16 |
2020-11-30 |
Ablynx Nv |
Immunglobulin variábilis domének
|
|
WO2016055656A1
(en)
|
2014-10-10 |
2016-04-14 |
Ablynx N.V. |
Methods of treating rsv infections
|
|
DK3204095T3
(da)
|
2014-10-10 |
2019-07-15 |
Ablynx Nv |
Inhalationsindretning til anvendelse i aerosolbehandling af luftsvejssygdomme
|
|
US9815886B2
(en)
|
2014-10-28 |
2017-11-14 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
US10441635B2
(en)
|
2014-11-10 |
2019-10-15 |
Biomet Biologics, Llc |
Methods of treating pain using protein solutions
|
|
CA2971278C
(en)
|
2014-12-19 |
2023-09-19 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
|
US9763800B2
(en)
|
2015-03-18 |
2017-09-19 |
Biomet C. V. |
Implant configured for hammertoe and small bone fixation
|
|
NO2768984T3
(enExample)
|
2015-11-12 |
2018-06-09 |
|
|
|
LT3374392T
(lt)
|
2015-11-13 |
2022-01-25 |
Ablynx Nv |
Patobulinti serumo albuminą surišantys imunoglobulino kintami domenai
|
|
WO2017085172A2
(en)
|
2015-11-18 |
2017-05-26 |
Ablynx Nv |
Improved serum albumin binders
|
|
CR20180279A
(es)
|
2015-11-18 |
2018-08-24 |
Merck Sharp & Dohme |
Enlazadores de ctla4
|
|
CA3022697A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
|
CN109313183B
(zh)
|
2016-06-23 |
2022-10-21 |
埃博灵克斯股份有限公司 |
免疫球蛋白单可变结构域的改进的药代动力学测定
|
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
|
IL310340A
(en)
|
2016-12-07 |
2024-03-01 |
Ablynx Nv |
Improved serum albumin binding immunoglobulin single variable domains
|
|
MX2019008536A
(es)
|
2017-01-17 |
2019-09-10 |
Ablynx Nv |
Aglutinantes de albumina serica mejorados.
|
|
KR102662499B1
(ko)
|
2017-01-17 |
2024-05-02 |
아블린쓰 엔.브이. |
개선된 혈청 알부민 결합제
|
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
|
CN110546506B
(zh)
|
2017-03-31 |
2023-04-04 |
埃博灵克斯股份有限公司 |
改进的免疫原性测定法
|
|
US20210155701A1
(en)
*
|
2018-05-30 |
2021-05-27 |
Chugai Seiyaku Kabushiki Kaisha |
Polypeptide comprising il-1r1 binding domain and carrying moiety
|
|
WO2021213435A1
(zh)
|
2020-04-22 |
2021-10-28 |
迈威(上海)生物科技股份有限公司 |
一种靶向人程序性死亡配体1(pd-l1)的单可变域抗体及其衍生物
|